Clinical Trial

Patients' Expectations About the Survival Benefits of Cancer Drugs Approved Based on Progression-Free Survival

Name: Patients' Expectations About the Survival Benefits of Cancer Drugs Approved Based on Progression-Free Survival — clinical trial record (NCT07731425)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study of current or former cancer patients will evaluate whether communicating data on overall survival data in addition to information on progression-free improves the accuracy of cancer patients' expectations about the survival benefits of new cancer drugs

Trial Details

NCT Number	NCT07731425
Lead Sponsor	London School of Economics and Political Science Collaborators: Harvard Medical School and Harvard Pilgrim Health Care Institute
Conditions	Cancer
Enrollment	3,000 participants
Start Date	2026-08-01
Primary Completion	2026-10-01 (estimated)
Study Completion	2026-10-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-28